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Chylopericardium represents a communication betweenthe pericardial cavity and the lymphatics.1,2 We report
the first case of chylopericardium caused by lung cancer with
superior vena cava (SVC) syndrome.
CASE REPORT
A previously healthy, 77-year-old Japanese man was
presented with a 2-week history of worsening dyspnea. At
presentation, he was in respiratory distress and orthopneic.
Blood pressure was 154/80 mmHg without paradoxical
pulses, respiratory rate was 16 per minute, and the oxygen
saturation was 97% with supplemental oxygen (3 L) by nasal
cannula. The face and upper extremities were edematous.
Computed tomography of the chest and echocardiography
showed moderate amounts of pericardial effusion but no
signs of tamponade (Figure 1A). Chylous effusion of 500 mL
was drained by pericardiocentesis, and dyspnea was relieved.
Analysis of the pericardial effusion revealed total protein at
5.2 g/dL, total cholesterol 212 mg/dL, and triglyceride 806
mg/dL. There were no malignant cells and no bacterial or
mycobacterial growth. The pericardial draining tube was
removed without chemical pericardiodesis. Primary adeno-
carcinoma of the lung and SVC syndrome were diagnosed
(Figure 1B). The TMN classification was cT3N3M0 
Stage3B. Pedal lymphatic scintigraphy using 99mTc-human
serum albumin revealed tracer accumulation in the mediasti-
nal lymph nodes but not in the pericardial cavity (Figure 2).
The patient selected best supportive care at diagnosis.
During the 4 weeks after the drainage, his dyspnea recurred.
Chest radiograph showed cardiomegaly and bilateral pleural
effusion (Figure 3A). Echocardiography revealed the reaccu-
mulation of pericardial effusion but not so much as to require
drainage again. Dexamethasone was started at 2 mg/d be-
cause of appetite loss and malaise. After 2 weeks of cortico-
steroid therapy, dyspnea and facial edema improved. Cardio-
megaly decreased and bilateral pleural effusion was resolved
(Figure 3B). Echocardiography demonstrated a decrease in
pericardial effusion. The patient continued dexamethasone
without a marked increase in pericardial effusion for 8
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FIGURE 1. A, Computed tomography (CT) of the chest on
admission showing moderate amounts of pericardial effu-
sion. B, Enhanced CT of the chest after drainage of pericar-
dial effusion showing marked swelling of the pretrachial and
subaortic lymph nodes. The superior vena cava is com-
pressed by the swollen lymph node and is hardly visible.
Collateral veins are also visible (black arrowhead).
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months, until he was transferred to another hospital for
terminal care.
DISCUSSION
Chylopericardium occurs as a result of trauma, congen-
ital anomalies, or as a complication of open-heart surgery,
mediastinal lymphangiomas, lymphangiomatous hamartoma,
lymphangiectasis, and obstruction or anomalies of the tho-
racic duct or the lymphatics.1 Although lung cancer often
involves the mediastinum, there had been no reports of
chylopericardium as a complication, except for postoperative
traumatic cases.3,4 In this case, because no communicating
route to the pericardial cavity was discovered, one probable
mechanism is that the obstruction of SVC by swollen medi-
astinal lymph nodes had caused congestion in the left sub-
clavian vein, which prevented lymphatic inflow.
In secondary chylopericardium, the underlying diseases
should be treated.1 Our patient’s chylopericardium was im-
proved after corticosteroid administration without any anti-
cancer treatment. The efficacy of corticosteroids in SVC
syndrome remains uncertain.5 One possibility is that the
compensatory development of collateral veins or lymphatics
reduced venous congestion s and improved lymphatic flow.
In conclusion, chylopericardium can occur as a complica-
tion of lung cancer with SVC syndrome. Corticosteroids can be
helpful in palliative care for NSCLC-related chylopericardium.
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FIGURE 2. A, Pedal lymphatic scin-
tigraphy with 99mTc human-serum
albumin showing tracer accumula-
tion in the mediastinal lymph nodes
1 hour after injection. B, This is
more prominent 21⁄2 hours after in-
jection, suggesting a congestion in
lymphatic flow. There is no accumu-
lation in the pericardial sac.
FIGURE 3. A, Chest radiograph on
readmission showing cardiomegaly
and bilateral pleural effusions. B,
After corticosteroid therapy for 2
weeks, cardiomegaly is reduced and
pleural effusions resolved.
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